dc.contributor.author | YAROVOY, Andrey | |
dc.contributor.author | Pe'er, Jacob | |
dc.contributor.author | MUNIER, Francis | |
dc.contributor.author | BERRY, Jesse | |
dc.contributor.author | HARBOUR, J. William | |
dc.contributor.author | LUCENA, Evandro | |
dc.contributor.author | MURRAY, Timothy G. | |
dc.contributor.author | BHAGIA, Pooja | |
dc.contributor.author | PAYSSE, Evelyn | |
dc.contributor.author | CHANTADA, Guillermo L. | |
dc.contributor.author | Moll, Annette C. | |
dc.contributor.author | USHAKOVA, Tatiana | |
dc.contributor.author | Plager, David A. | |
dc.contributor.author | ZIYOVUDDIN, Islamov | |
dc.contributor.author | LEAL, Carlos A. | |
dc.contributor.author | MATERIN, Miguel A. | |
dc.contributor.author | JI, Xun-Da | |
dc.contributor.author | CURSINO, Jose W. | |
dc.contributor.author | POLANIA, Rodrigo | |
dc.contributor.author | Kiratli, Hayyam | |
dc.contributor.author | ALL-ERICSSON, Charlotta | |
dc.contributor.author | HONAVAR, Santosh G. | |
dc.contributor.author | VISHNEVSKIA-DAI, Vicktoria | |
dc.contributor.author | EPELMAN, Sidnel | |
dc.contributor.author | Daniels, Anthony B. | |
dc.contributor.author | Ling, Jeanie D. | |
dc.contributor.author | TRAORE, Fousseyni | |
dc.contributor.author | RAMIREZ-ORTIZ, Marco A. | |
dc.contributor.author | Kebudi, Rejin | |
dc.contributor.author | Tuncer, Samuray | |
dc.contributor.author | SCELFO, Christina | |
dc.contributor.author | FRANCIS, Jasmine H. | |
dc.contributor.author | KHETAN, Vikas | |
dc.contributor.author | JENKINS, Thomas | |
dc.contributor.author | MARR, Brian | |
dc.contributor.author | ABRAMSON, David H. | |
dc.contributor.author | SHIELDS, Carol L. | |
dc.date.accessioned | 2021-03-03T20:01:25Z | |
dc.date.available | 2021-03-03T20:01:25Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | SCELFO C., FRANCIS J. H. , KHETAN V., JENKINS T., MARR B., ABRAMSON D. H. , SHIELDS C. L. , Pe'er J., MUNIER F., BERRY J., et al., "An international survey of classification and treatment choices for group D retinoblastoma", INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, cilt.10, sa.6, ss.961-967, 2017 | |
dc.identifier.issn | 2222-3959 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_57b0af4f-555e-4ed1-b983-8f799e329724 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/61822 | |
dc.identifier.uri | https://doi.org/10.18240/ijo.2017.06.20 | |
dc.description.abstract | AIM: To determine which IIRC scheme was used by retinoblastoma centers worldwide and the percentage of D eyes treated primarily with enucleation versus globe salvaging therapies as well as to correlate trends in treatment choice to IIRC version used and geographic region. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Göz Hastalıkları ve Cerrahisi | |
dc.subject | Klinik Tıp | |
dc.subject | OFTALMOLOJİ | |
dc.title | An international survey of classification and treatment choices for group D retinoblastoma | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF OPHTHALMOLOGY | |
dc.contributor.department | Memorial Sloan Kettering Cancer Center , , | |
dc.identifier.volume | 10 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 961 | |
dc.identifier.endpage | 967 | |
dc.contributor.firstauthorID | 23926 | |